AmSurg Corp
AMSG
NASDAQ67.75
USD
-0.37
- -
AmSurg Corp
AMSG
(NASDAQ)
Recent
price
67.75
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- AmSurg Corp (NYSE: AMSG) operates as a leading developer and manager of ambulatory surgery centers (ASCs) and surgical facilities in the United States. The company provides comprehensive management services to ASCs, including physician recruitment, staffing, marketing, billing and collections, and information systems support; it also offers equity investments in ASC partnerships and development services for new facilities. AmSurg focuses on multiple surgical specialties, such as ophthalmology, orthopedics, gastroenterology, pain management, and otolaryngology, serving physicians, patients, and payors through a network of over 230 ASCs across more than 35 states as of its most recent reporting. Founded in 1992 and headquartered in Nashville, Tennessee, AmSurg derives revenue primarily from management fees, administrative service fees, and its equity earnings from ASC partnerships. The company targets outpatient surgical procedures, emphasizing cost-effective alternatives to hospital-based surgery for commercial insurers, Medicare, and managed care organizations. Its operations remain concentrated in the U.S., with no significant international presence. In recent developments, AmSurg merged with Envision Healthcare in 2019 to form SCA Health, a major restructuring that shifted its standalone operations under a new parent entity focused on broader physician services and ASC management. This transaction integrated AmSurg's ASC platform with Envision's anesthesia and physician services, enhancing scale and service offerings. No major new acquisitions, funding rounds, or product launches have been reported for AmSurg as a distinct entity in the last 1-2 years, reflecting its post-merger stability within SCA Health.